ELVN Enliven Therapeutics, Inc.
ELVN Enliven Therapeutics, Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-08-17 1 bull converging
POC $19.73 · VWAP $34.84 · +70.9% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 watchlist
ELVN Price Structure
Loading timeframes…
Peers
Every watchlist ELVN belongs to, members best 30-day change first — ELVN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Decision history
1 scored call · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Reported EPS $-0.49 versus analyst consensus of $-0.36 (-37.4%).
full note →Against street estimates
How ELVN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about ELVN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 58 days ago · Jun 21
- Enliven Therapeutics (ELVN) Short Interest & Short Float | Updated Jun 2026
- Enliven Therapeutics (ELVN) Stock Price, News & Analysis
- Enliven Therapeutics (ELVN) — Stock Premarket
- Enliven Therapeutics Reports Positive Phase 1 Data - ELVN | BioPh
- ELVN Stock Jumps As Analysts Hike Price Targets - StocksToTrade
ELVN research tape
35 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.